Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapy

K C Remant1, Bindu Thapa2, Juliana Valencia-Serna3

  • 1Department of Chemical & Material Engineering, Faculty of Engineering, University of Alberta, Edmonton, Alberta, Canada.

Insights

Researchers developed cholesterol-grafted polyethylenimines (PEI-Chol) for targeted siRNA delivery to chronic myeloid leukemia (CML) cells. This novel system effectively silenced cancer genes, inhibiting CML cell growth and promoting apoptosis for potential molecular therapy.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Molecular Biology

Background:

  • Synthetic small interfering RNA (siRNA) holds promise for cancer molecular therapy via post-transcriptional gene silencing.
  • Efficient delivery systems are crucial, especially for challenging, anchorage-independent cancer cells like those in chronic myeloid leukemia (CML).

Purpose of the Study:

  • To design and evaluate novel, hydrophobic cationic lipopolymers for targeted siRNA delivery to CML cells.
  • To investigate the efficacy of these carriers in gene silencing and therapeutic effects on CML cells.

Main Methods:

  • Grafting cholesterol (Chol) onto low-molecular weight polyethylenimines (PEIs) to create PEI-Chol lipopolymers.
  • Characterization of PEI-Chol/siRNA polyplexes for size, ζ-potential, and serum stability.
  • Assessment of siRNA delivery, gene silencing (GFP, BCR-Abl, KSP), cell growth arrest, colony formation, caspase activity, and apoptosis in K562 CML cells.

Main Results:

  • Nano-sized (100-200 nm) PEI-Chol polyplexes with enhanced ζ-potential (+20 to +35 mV) were formed, protecting siRNA in serum.
  • siRNA delivery and gene silencing efficacy correlated with cholesterol substitution and inversely with PEI molecular weight.
  • PEI-Chol effectively silenced BCR-Abl and KSP genes, significantly inhibiting K562 cell growth, colony formation, and inducing apoptosis.

Conclusions:

  • Cholesterol-grafted low-molecular weight PEIs are effective carriers for siRNA delivery to CML cells.
  • This technology shows potential for realizing molecular therapy in CML by targeting specific oncogenes.
  • PEI-Chol offers a unique approach for overcoming delivery challenges in difficult-to-transfect cancer cells.